Gbirgand

Détails de l'auteur

Nom : Gabriel Birgand
Date d'enregistrement : 22 décembre 2010

Derniers articles

  1. ICPIC 2023 – Geneva – Innovation for infection prevention and control – Learning from Pasteur’s vision — 18 septembre 2023
  2. ICPIC 2023 – Geneva – Surgical Environment and Operating Room Discipline: Keys to Infection Control — 18 septembre 2023
  3. Contamination virale de l’air en établissement de santé – SF2H 2023 — 8 juin 2023
  4. Chirurgies et médecines interventionnelles hors du bloc opératoire – SF2H 2023 — 8 juin 2023
  5. Entérobactéries résistantes aux antibiotiques en population générale: Que savons nous? — 28 avril 2023

Articles de cet auteur

mai 28

Controlling healthcare-associated transmission of SARS-CoV-2 Variant of Concern 202012/01 in a large hospital network

Controlling healthcare-associated transmission of SARS-CoV-2 Variant of Concern

mai 28

Myths on airborne transmission of SARS-CoV-2

Diapositive1

mai 28

Transmission-of-SARS-CoV-2-from-asymptomatic-and-presymptomatic-individuals in healthcare settings despite medical masks and eye protection

Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals

mai 28

SARS-CoV-2 routes of transmission and recommendations for preventing acquisition in England

SARS-CoV-2 routes of transmission and recommendations for preventing

mai 20

Evaluating the Presence of Replication-Competent SARS-CoV-2 from Nursing Home Residents with Persistently Positive RT-PCR Results

Evaluating the Presence of Replication-Competent SARS-CoV-2 from Nursing

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab436/6275595

mai 06

Hand Hygiene Compliance Rate During the COVID-19 Pandemic

Hand Hygiene Compliance Rate

doi:10.1001/jamainternmed.2021.1429

avr 08

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

Diapositive1

Viral load substantially decrease 12 days, 2.8–4.5-fold, after vaccination with the first BNT162b2 vaccine dose. https://www.nature.com/articles/s41591-021-01316-7

mar 22

Neutralizing-antibody response to 4 variants in infected and vaccinated individuals.

Sans titre

https://jamanetwork.com/journals/jama/fullarticle/2777898?resultClick=1

mar 18

SARS-CoV-2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island

Diapositive3

https://wwwnc.cdc.gov/eid/article/27/3/pdfs/20-4508-combined.pdf

mar 15

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Sans titre 3

https://www.bmj.com/content/372/bmj.n579

Articles plus anciens «

» Articles plus récents

Plugin developed by Jon Fox